| Tag | Content |
|---|
EnhancerAtlas ID | HS134-04688 |
Organism | Homo sapiens |
Tissue/cell | Mesendoderm |
Coordinate | chr1:209560140-209561250 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOXA1 | MA0148.4 | chr1:209560583-209560599 | ATCTGTTTACTTAGTG | - | 6.43 | | FOXP1 | MA0481.2 | chr1:209560583-209560595 | ATCTGTTTACTT | - | 6.74 | | FOXP2 | MA0593.1 | chr1:209560584-209560595 | TCTGTTTACTT | - | 6.32 | | Foxa2 | MA0047.2 | chr1:209560586-209560598 | TGTTTACTTAGT | + | 6.44 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_26692 | chr1:209560154-209563829 | Esophagus | | SE_33755 | chr1:209555198-209563762 | HCC1954 | | SE_35814 | chr1:209555516-209564886 | HMEC | | SE_64219 | chr1:209555655-209563883 | NHEK |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I209382 | chr1 | 209555746 | 209564565 |
|
Enhancer Sequence | GTATTTTAAA CTTTGTGACA ATGGGCAGAA CAGCAACAAG GAAAGCAGGC CAAGGCACTG 60
GGTTTGGAGT CAAGAGATGG GTTTTATCCT GGTTATATGT TGAATTTACT TCCCACCTTG 120
GGCAAATCAC TTCCCTATCT AATCAGTTTC CTAACCTGTA AAATGACAAA AATCACTTCC 180
ACTTCCTAGT TTTATGATTC CAGGTCCAAT ACAAGAAGGA ATTTCTTTTA AGGGCCCCCT 240
TAATCTGGTC AAAGTTATCC TTCCCAGCAG GGCAGAAACT TCACCTGTTT GCATTAGGCC 300
TGGGTTGTGG GATAAGCTAT CTCCTGACAG ACCCCAAGAG TCTCCATCTT CCAGTCCTCC 360
CCAAGTGACC CCATGAGAAG ACGTATTAAA GGAAGGAATT CAAAACAGTA TGGCCCATGT 420
AAAGAGTATC CTTTAGGAAC AGGATCTGTT TACTTAGTGG CTGGAAACTT AAATGCATGC 480
ATTGTATACC GCCCAACCCC CAACTCCCCA CCCCCACTGC TATCATAGCC ATTAAAAAAA 540
GGAGCATAGC AGATCTCTGA CAGTTAGACC TTACCCATTT TCAGCTCTGG ACTTTCACTG 600
AGGTAATATC TTTACCTGTT GCCAACTAGA CCTGTTGGTG TGTGTAACTG TTTCTTCATT 660
CTGACTCATC ACACCTTGCT TGTGGCAGCG AACCCAGGCG CCATTGTTTC CTGGTGATCT 720
CTGGCCTACT TTTTCCCAAA CGCTGTGAGG CAGCCATGGA GCCTTGTGAA AGAGATTGAC 780
TTTCTCTCAG GTAGCCAAGG GCCTTTGGGA CAGCTACCTC CTGATCCCCT TTAACCCCAG 840
GGGGAACTCT GAAGGCTGAG CCCCTCCTAA GTTACAACAT AGAAGTTAGT TCCAGTAAAA 900
CTTTCCAGGC TCTGCTAATT CCATAAGGGA CTCTTAAAGA ATGAGAAATG GAAGCCCAAG 960
GTCTGCATAA AATCCTACAT GTGCTAAGCC CGCCAAAATC AGTTTGTTGA GGAGAAGGAG 1020
CACAGTAGGA AGAGCTTTTG TATTTTCAAT TCAGATAAAC CCCAGTAAGA CTAGCCATAG 1080
GGCAACATAG AACTGCTTAT GGTTCCATAT 1110
|
